China Pharma (CPHI) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

Closed at $0.73, +1.39% vs the prior close of $0.72.
Volume 330.60K shares, 0.1x its 50-day average (light).
No new SEC filings since the prior session.
No new insider buys or sales reported since the prior session.

CPHI rises 1.4% to $0.73. Closed at $0.73, +1.39% vs the prior close of $0.72. Day range $0.67–$0.74, opened at $0.72.

Last close$0.73+1.39%

Day range0.67–0.74

Open0.72

Volume330.60K

52-week range0.38–19.19

Avg volume (20d)4.80M

CPHI daily analysis — what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 — CPHI rises 1.4% to $0.73

Closed at $0.73, +1.39% vs the prior close of $0.72. Day range $0.67–$0.74, opened at $0.72.
Volume was 330.60K shares, 0.1x its 50-day average of 2.35M — lighter than usual.
Price is -14.7% vs its 50-day average ($0.86) and -15.5% vs its 200-day average ($0.86).
52-week range $0.38–$19.19; today's close sits at 2% of that range, 96.2% below the 52-week high.

Oct 14, 2026 — CPHI slides 4.0% to $0.72, 4 down days in a row

Closed at $0.72, -4.00% vs the prior close of $0.75. Day range $0.67–$0.72, opened at $0.72.
Volume was 306.60K shares, 0.1x its 50-day average of 2.35M — lighter than usual.
Price is -16.9% vs its 50-day average ($0.87) and -16.9% vs its 200-day average ($0.87).
52-week range $0.38–$19.19; today's close sits at 2% of that range, 96.2% below the 52-week high.
That makes 4 straight losses.

Oct 13, 2026 — CPHI slides 13.8% to $0.75, 3 down days in a row

Closed at $0.75, -13.79% vs the prior close of $0.87. Day range $0.69–$0.87, opened at $0.84.
Volume was 586.00K shares, 0.2x its 50-day average of 2.35M — lighter than usual.
Price is -14.3% vs its 50-day average ($0.88) and -13.7% vs its 200-day average ($0.87).
52-week range $0.38–$19.19; today's close sits at 2% of that range, 96.1% below the 52-week high.
That makes 3 straight losses.

Oct 12, 2026 — CPHI ends flat (+0.0%) to $0.87

Closed at $0.87, +0.00% vs the prior close of $0.87. Day range $0.74–$0.87, opened at $0.80.
Volume was 967.30K shares, 0.4x its 50-day average of 2.34M — lighter than usual.
Price is -1.5% vs its 50-day average ($0.88) and -0.2% vs its 200-day average ($0.87).
52-week range $0.38–$19.19; today's close sits at 3% of that range, 95.5% below the 52-week high.

Oct 9, 2026 — CPHI slides 9.4% to $0.87

Closed at $0.87, -9.37% vs the prior close of $0.96. Day range $0.80–$1.09, opened at $0.92.
Volume was 2.29M shares, 1.0x its 50-day average of 2.32M.
Price is -2.0% vs its 50-day average ($0.89) and -0.5% vs its 200-day average ($0.87).
52-week range $0.38–$19.19; today's close sits at 3% of that range, 95.5% below the 52-week high.

Oct 8, 2026 — CPHI jumps 12.9% to $0.96, a 1-month high on 10.4x normal volume

Closed at $0.96, +12.94% vs the prior close of $0.85. Day range $0.74–$1.19, opened at $0.77.
Volume was 20.04M shares, 10.4x its 50-day average of 1.93M — unusually heavy trading.
Price is +7.1% vs its 50-day average ($0.90) and +9.5% vs its 200-day average ($0.88).
52-week range $0.38–$19.19; today's close sits at 3% of that range, 95.0% below the 52-week high.

Oct 7, 2026 — CPHI jumps 32.8% to $0.85, a 1-month high on 113.5x normal volume

Closed at $0.85, +32.81% vs the prior close of $0.64. Day range $0.64–$1.28, opened at $0.68.
Volume was 67.51M shares, 113.5x its 50-day average of 594.97K — unusually heavy trading.
Price is -5.7% vs its 50-day average ($0.90) and -3.3% vs its 200-day average ($0.88).
52-week range $0.38–$19.19; today's close sits at 2% of that range, 95.6% below the 52-week high.

Oct 6, 2026 — CPHI dips 1.5% to $0.64, a 1-month low

Closed at $0.64, -1.54% vs the prior close of $0.65. Day range $0.64–$0.67, opened at $0.64.
Volume was 129.60K shares, 0.2x its 50-day average of 616.38K — lighter than usual.
Price is -29.7% vs its 50-day average ($0.91) and -27.4% vs its 200-day average ($0.88).
52-week range $0.38–$19.19; today's close sits at 1% of that range, 96.7% below the 52-week high.

Oct 5, 2026 — CPHI dips 1.5% to $0.65

Closed at $0.65, -1.52% vs the prior close of $0.66. Day range $0.64–$0.68, opened at $0.64.
Volume was 118.40K shares, 0.2x its 50-day average of 688.08K — lighter than usual.
Price is -29.5% vs its 50-day average ($0.92) and -26.6% vs its 200-day average ($0.89).
52-week range $0.38–$19.19; today's close sits at 1% of that range, 96.6% below the 52-week high.

Oct 2, 2026 — CPHI rises 1.5% to $0.66

Closed at $0.66, +1.54% vs the prior close of $0.65. Day range $0.64–$0.66, opened at $0.64.
Volume was 118.90K shares, 0.1x its 50-day average of 896.15K — lighter than usual.
Price is -29.8% vs its 50-day average ($0.94) and -25.8% vs its 200-day average ($0.89).
52-week range $0.38–$19.19; today's close sits at 1% of that range, 96.6% below the 52-week high.

CPHI latest news & SEC filings

Every SEC filing by or about CPHI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Aug 14, 2026 · Form 10-Q — Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Revenue: $948.34K (prior year $1.03M) (-7.5% vs Jun 30, 2025)
Net income: -$1.46M (prior year -$528.37K) (loss widened vs Jun 30, 2025)
Diluted EPS: -$0.04 (prior year -$0.16) (loss narrowed vs Jun 30, 2025)

Source: SEC EDGAR filing 0001213900-26-090173

Jul 23, 2026 · Form 424B5 — Prospectus supplement

Prospectus supplement — the company is selling securities off a shelf registration

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-080581

Jul 22, 2026 · Form 8-K — Major event / current report

Current report — a filing companies must make within 4 business days of a major event

Item 1.01 — Signed a material agreement.
Item 8.01 — Reported other events the company considers important.

Source: SEC EDGAR filing 0001213900-26-080475

Things to know before you trade CPHI

Last results release: Mar 31, 2017 (8-K Item 2.02). Previous ones: Feb 28, 2008, Sep 21, 2006. Based on that rhythm, the next report is likely around Jun 30, 2017 — an estimate, not a confirmed date.
How much it moves: over the last 20 sessions the average daily move was 5.65% (largest 32.8%). That is a volatile stock.
Liquidity: about 4.80M shares (≈$3.51M) trade per day on average.
52-week position: $0.73 vs a range of $0.38–$19.19 (2% of the range).
Dividends: no cash dividends in the last 2 years.
Splits: 1:10 on Apr 15, 2025
Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
Latest filings: 10-Q Aug 14, 2026; 8-K Jul 22, 2026; 10-Q May 15, 2026.
Share count: 43.02M shares outstanding (Aug 11, 2026), +1218.9% vs a year earlier — notable dilution.
Listing: NYSE · industry: Pharmaceutical Preparations.

CPHI market data (last 20 sessions)

Date	Open	High	Low	Close	Volume
Oct 15, 2026	0.72	0.74	0.67	0.73	330.60K
Oct 14, 2026	0.72	0.72	0.67	0.72	306.60K
Oct 13, 2026	0.84	0.87	0.69	0.75	586.00K
Oct 12, 2026	0.80	0.87	0.74	0.87	967.30K
Oct 9, 2026	0.92	1.09	0.80	0.87	2.29M
Oct 8, 2026	0.77	1.19	0.74	0.96	20.04M
Oct 7, 2026	0.68	1.28	0.64	0.85	67.51M
Oct 6, 2026	0.64	0.67	0.64	0.64	129.60K
Oct 5, 2026	0.64	0.68	0.64	0.65	118.40K
Oct 2, 2026	0.64	0.66	0.64	0.66	118.90K
Oct 1, 2026	0.66	0.66	0.63	0.65	100.80K
Sep 30, 2026	0.66	0.66	0.64	0.66	78.60K
Sep 29, 2026	0.71	0.71	0.61	0.65	200.20K
Sep 28, 2026	0.74	0.76	0.71	0.72	138.00K
Sep 25, 2026	0.72	0.94	0.71	0.75	2.27M
Sep 24, 2026	0.72	0.77	0.70	0.74	302.20K
Sep 23, 2026	0.67	0.73	0.66	0.72	220.30K
Sep 22, 2026	0.70	0.72	0.65	0.67	162.10K
Sep 21, 2026	0.69	0.73	0.68	0.68	80.30K
Sep 18, 2026	0.73	0.74	0.71	0.71	142.50K

About China Pharma

China Pharma (CPHI) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in HAINAN PROVINCE, China. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1106644.

CPHI board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

Name	Role	Latest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

Name	Title	Latest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

Date	Insider	Type	Shares	Price
No open-market insider buys or sales reported in the last 12 months.

CPHI financials (annual, from XBRL filings)

Fiscal year end	Revenue	Net income	Diluted EPS	Operating cash flow
Dec 31, 2025	$4.14M	$-3.19M	-0.74	$148.26K
Dec 31, 2024	$4.53M	$-4.74M	-2.71	$-406.06K
Dec 31, 2023	$7.01M	$-3.08M	-0.91	$-699.69K
Dec 31, 2022	$8.10M	$-3.97M	-3.78	$-409.55K
Dec 31, 2021	$9.64M	$-3.40M	-0.74	$-249.84K

Latest balance sheet: total assets $44.71M, total liabilities $8.53M, cash $304.87K (as of Jun 30, 2026).

CPHI earnings / results-day log

Date	Filing	Close that day
Mar 31, 2017	8-K Item 2.02 (results)	—
Feb 28, 2008	8-K Item 2.02 (results)	—
Sep 21, 2006	8-K Item 2.02 (results)	—

Related stocks · Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)

More on CPHI

CPHI news & filings feed

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.